Abstract Background: Baseline prognostic biomarkers stratifying treatmentstrategies in first-line metastatic...
Posté par : Pr. Franck BONNETAIN, Dr. Dewi VERNEREY
Nom de la revue :
BACKGROUND:A randomized multicenter phase II trial was conducted to assess the sequential treatment strategy using...
Posté par : Pr. Franck BONNETAIN, , Dr. Sophie PAGET-BAILLY
Nom de la revue : PlosOne
AbstractOverall survival (OS) has been considered as the most relevant primary endpoint but trials using OS often...
Posté par : Pr. Franck BONNETAIN, Dr. Dewi VERNEREY, Dr. Sophie PAGET-BAILLY
Nom de la revue : Expert Review of Anticancer Therapy